ArticleFrontiers in immunology2024

Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.

Jie Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.